Saltar al contenido
Merck

Responses to noxious stimuli in sedated mechanically ventilated adults.

Heart & lung : the journal of critical care (2013-11-19)
Mary Jo Grap, Cindy L Munro, Paul A Wetzel, Jessica M Ketchum, V Anne Hamilton, Curtis N Sessler
RESUMEN

To determine the effect of sedation on physiologic responses and comfort before, during and after a noxious stimulus (endotracheal tube suctioning). The sample was a subset of a larger, longitudinal descriptive study, blood for endorphins and saliva for alpha-amylase were obtained before and after suctioning. Heart rate (HR), respiration rate (RR), oxygen saturation (SPO2), and arm and leg actigraphy were continuously recorded. 67 subjects from medical and surgical ICUs were primarily deeply (37%) or mildly sedated (54%) prior to suctioning. Alpha-amylase increased post suctioning (p = 0.04); endorphins did not change (p = 0.58). Neither were modified by sedation. There were no changes in HR, RR or SPO2 post suctioning. Arm (p = 0.007) and leg actigraphy (p = 0.057) changed from baseline and depended on sedation level (p = 0.0005). While a stress marker did increase during suctioning, only the measure of patient arm movement was significantly affected by sedation level.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
αα-Amilasa termoestable, solution, for use in Total Dietary Fiber Assay, TDF-100A
Sigma-Aldrich
αα-Amilasa from human saliva, Type XIII-A, lyophilized powder, 300-1,500 units/mg protein
Sigma-Aldrich
α-Amylase from porcine pancreas, Type VI-B, ≥5 units/mg solid
Sigma-Aldrich
Taka-diastasa from Aspergillus oryzae, powder, slightly beige, ~100 U/mg
Sigma-Aldrich
αα-Amilasa from Aspergillus oryzae, powder, ~30 U/mg
Sigma-Aldrich
αα-Amilasa from Bacillus licheniformis, Type XII-A, saline solution, ≥500 units/mg protein (biuret)
Sigma-Aldrich
αα-amilasa from Bacillus sp., Type II-A, lyophilized powder, ≥1,500 units/mg protein (biuret)
Sigma-Aldrich
αα-Amilasa from Aspergillus oryzae, ≥150 units/mg protein (biuret)
Sigma-Aldrich
αα-Amilasa from Bacillus licheniformis, lyophilized powder, 500-1,500 units/mg protein, 93-100% (SDS-PAGE)
Sigma-Aldrich
αα-Amilasa from human saliva, Type IX-A, lyophilized powder, 1,000-3,000 units/mg protein
Sigma-Aldrich
α-Amylase from Bacillus sp., powder, yellow-brown, ~50 U/mg
Sigma-Aldrich
αα-Amilasa from Aspergillus oryzae, powder, ~1.5 U/mg (~0.2 U acc. to Willstätter)
Sigma-Aldrich
α-Amylase from Bacillus sp., liquid
Sigma-Aldrich
α-Amylase from porcine pancreas, PMSF Treated, Type I-A, saline suspension, ≥1000 units/mg protein (E1%/280)
Sigma-Aldrich
αα-amilasa from Bacillus sp., powder, ≥400 units/mg protein (Lowry)
Sigma-Aldrich
αα-Amilasa from Aspergillus oryzae, aqueous solution, ≥800 FAU/g
Sigma-Aldrich
α-Amylase from Bacillus amyloliquefaciens, liquid, ≥250 units/g
Sigma-Aldrich
α-Amylase from Bacillus sp., powder, yellow-brown, ~380 U/mg
Sigma-Aldrich
α-Amylase from porcine pancreas, Type I-A, PMSF treated, saline suspension, 700-1400 units/mg protein (E1%/280)
Supelco
αα-Amilasa from Bacillus licheniformis, suitable for determination of starch (Kit STA-20)